COPIED
5 mins

Pieces of the puzzle

Focusing on patient–practitioner compatibility can give a better insight into patient psychology, says Dr Nestor Demosthenous.

DR NESTOR DEMOSTHENOUS.

Dr Nestor Demosthenous (MBChB, MSc Aesth Med, BSc Hons Neuro Edin) is one of Scotland’s most experienced cosmetic doctors and an international speaker and published author in the field of aesthetic medicine. He opened Dr Nestor’s Medical Cosmetic Centre in Edinburgh in 2016. He also holds regular clinics at London’s PHI Clinic and more recently, Ouronyx. Follow him on Instagram: @ dr_nestor_dDr Nestor Demosthenous.

One of the less acknowledged but highly important aspects inherent in the role of a cosmetic doctor is an ability to dissect the thinking of the patients entrusted to their care. In a world that has become dominated by social media, body dysmorphia is a big concern, so it is crucial that doctors can speak frankly and openly to their patients during consultation to understand why they are choosing to have intervention and to ensure that those reasons are valid and are not a result of an unrealistic vision a patient has of themselves. Not to mention, the cultural phenomenon of “Zoom face” has pushed the psychology behind cosmetic treatments into the spotlight.

With a special interest in patient psychology, Dr Nestor Demosthenous was approached to be one of a selected group of visiting aesthetic practitioners at new luxury clinic Ouronyx London, which places a high emphasis on “next generation” personalised treatments and the relationship between patient and practitioner. We spoke to Dr Demosthenous to discuss the important and dutiful role doctors have in understanding patient mindset and how this assessment can be used to positively influence a patient’s aesthetics journey.

Why do patients have the treatments they do?

ND: I always want to understand the “why”. In every case, almost without exception, something powerful and visceral has pushed a patient into action.There is always something that has led them into thinking “I don’t like my lines. I need [toxin]” or,“I don’t like my jowls, I need filler.” My fundamental role, prior to treatment, is to understand what this something is. Once I understand it, I can talk the patient through treatment options and their various outcomes to devise a plan that will address and alleviate their issue and make them feel terrific about how they look.

What is the approach at Ouronyx and how does this fit in with your own?

ND:The cornerstone of successful treatment is understanding patients, so once I understand my patient’s reasoning – their “why, as it were –I can treat them with confidence. My approach to treatment centres on holistically treating the face, rather than focusing on a single feature. I want to celebrate the individual beauty of each of my patients and enhance their facial features so they can become the best version of themselves. I also never want my patients to look as if they have “had work done”, rather my intervention will look natural, respecting proportions, angles and ratios to accentuate natural beauty.This modus operandi aligns perfectly with the Ouronyx philosophy.

Ouronyx offers a unique diagnostic approach, which blends anatomical, psychological, and behavioural sciences, to fully cater to each patient’s aesthetic needs.This holistic, scientific approach allows Ouronyx to understand the patient’s personality type and whether they fall into a green, red, yellow, or blue colour code, which will indicate the type of person they are, i.e., whether they are a flamboyant person, an instant decision maker, someone who needs facts and details, etc.

This is something we have been doing in healthcare intuitively for a while now, as it allows us to gauge a patient’s journey and to gain a better understanding of how much or how little information they need regarding the treatment to feel comfortable and informed – Ouronyx has formalised this process to ensure it is more accurate than ever.

The Ouronyx philosophy hinges on understanding what drives the patient and what they feel (i.e.,“I feel I look tired, sad”, etc.) rather than focusing on what they want (i.e.,“I want lip filler”,“I want to get rid of lines”, etc.). It’s a completely tailored approach. Once we understand how the patient feels, we can start to optimise bespoke journeys for them to achieve a refined and unique outcome. Furthermore, the advanced technologies available at Ouronyx allow us to help patients realise their best self – we can help them identify distinctive features and preserve these features with a relaxed formulation that will ensure the result is as natural as possible.

How does Ouronyx “match” patients to doctors, and why this is important?

ND: Every clinician who works at Ouronyx has taken psychometric testing, which is a short questionnaire of approximately seven or eight questions.This allows the team to profile each of us as individuals and then they can use this insight to try to match up our profiles with the patient profiles.This leads to a better patient-doctor compatibility. By having a compatible relationship between doctor and patient, you build trust and understanding, which will ensure an optimum patient journey moving forward.

What’s the difference between the treatment a patient wants and the treatment their doctor feels they actually need?

ND: What people feel is 100% accurate, but from my experience what they think isn’t always in line with how they feel. For example, I might receive a visit from a 60-year-old who wants her jowls taken away because they make her feel like she looks tired. If we break it down, though, you will see that her thought process is inaccurate. She feels like she looks tired, and she is probably faultless in her assessment, but it is not the jowls that are the sole issue.

She perhaps has hooded upper eyelids, hollowing underneath the eyes and eyebags as well as jowling, each of which are signs of tiredness and give a cumulative result of an appearance of fatigue. So, she has read her face correctly but jumped to conclusions that are not wholly correct.This is the surface we need to scratch with every patient – to understand their “why”. Once we know, we can outline to them the measures that we can take that will give them the best possible result and ensure they achieve the outcome they want, even if it isn’t the exact treatment they expected.

This article appears in Jan-Feb 2022

Go to Page View
This article appears in...
Jan-Feb 2022
Go to Page View
Pieces of the puzzle
Focusing on patient–practitioner compatibility can give a better insight into patient psychology, says Dr Nestor Demosthenous
Ask Alex
Clinic digital marketing specialist Alex Bugg answers your questions.
Time for change
Why aren’t we doing more about climate change in aesthetics?, asks Ron Myers.
OUR EXPERTS
The Aesthetic Medicine editorial board includes some of the leading names in aesthetics. Their clinical expertise and diverse range of specialties will help ensure the magazine meets the needs of its readers
Managing Practice & Patients
Shriyal Sethumadhavan assesses the impact of the last two years on practices and connects with aesthetic practitioners and experts to delve into how they have managed their practice and patients.
aesthetic MEDICINE
aestheticmed.co.uk/live2022
POWER OF 4
Harshal Limaye shares four keys to effective patient management for your aesthetic practice.
Taking an EYE VIEW
Evaluating the effectiveness and safety of a topical under-eye serum, Melalumin, covering clinical finds and patient satisfaction, in the treatment of periorbital hyperpigmentation, Aesthetic Medicine India – in association with Menarini Group – presents a detailed analysis
Periorbital hyperpigmentationtreatment with topical under-eye serum (Melalumin® Under Eye Serum)
Periorbital hyperpigmentation (POH) (synonyms: under eye dark circles,
Start afresh
Make 2022 the year that you prioritise your mental health, and see how it impacts your business,
WE ARE BACK WITH PHYSICAL EVENTS!
Successful medical practice has to be backed by
Welcome to the Let’s Talk Series
Aesthetic Medicine India, in association with Galderma, has launched the Let’s Talk Series. Here’s a sneak peek into the focus of the series and episodes that have gone live
Melasma & Hyperpigmentation Management
Discussing case studies from India and across the globe Date: Saturday, 11 December 2021
Leaderma Hair Care Clinical Shampoo and Serum
The advanced clinical formulation of Leaderma Hair Care
REJSOL adds TCA 100% for Cross
REJSOL adds TCA 100% for Cross, one more
Skin Aesthetics ND Cell for neck and décolleté area
Beautiful neck and décolleté lines are a symbol
Nusaude Fish Oil Softgels by Skinnovation Next
Skinnovation Next is proud to announce the launch
Stabilised retinol for anti-wrinkle
Amvigor Organics are proud to announce that the
Increase in muscle mass and fast reduction with EM Sculpt from Skinlasers
Get a 16 per cent average increase in
By 2030, non-invasive aesthetic treatment market projected to hit US$ 150.6 billion
The non-invasive aesthetic treatment market size is projected
Medical Botox Creator Ophthalmologist dies at 89
At the age of 89, it is known
Galderma’s new SCULPTRA® Label, the first and only FDA-approved PLLA facial injectable treatment
Galderma announces the new label for SCULPTRA ®
Orah Nutrichem launches ORAH Vit E, a tocotrienolbased natural anti-oxidant
Pune-based Orah Nutrichem has successfully launched ORAH Vit
KGMU surgeon wins global acclaim
A discovery was recently made in the city
Facial injectable market to reach US$ 9.07 billion by 2028
The global ‘facial injectables market’ size is expected
IASRM organises online scientific event on regenerative medicine
On January 8, 2022, IASRM organised a one-day
Dr Neeraj Pandey and Dr Tulika Pandey emerge winners at the ET Inspiring Leaders Awards
ET Inspiring Leaders-Northern States Destination Lucknow is an
Growing focus on dental aesthetics to drive the market: Cosmetic Dentistry Market
The growing focus on dental aesthetics, dental tourism
Dr Fan Liang, MD, to be the next Medical Director of The Johns Hopkins Centre for Transgender Health
Johns Hopkins Medicine has announced that plastic and
Botulinum toxin market size to grow to US$ 5.68 billion in 2028
The botulinum toxin market is projected to grow
Allergan Aesthetics announces open casting call for BOTOX® cosmetic
Allergan Aesthetics, an AbbVie company (NYSE: ABBV), has
Acne treatment market anticipated to reach US$ 19.03 billion by 2028-end
The acne treatment market size reached US$ 12.41
Beauty and cosmetic care clinic Aesthetica Veda Bangalore’s launched in Bengaluru
The first centre of Aesthetica Veda, a beauty
Galderma successfully completes the acquisition of ALASTIN Skincare®
Galderma has received antitrust clearance from the US
Looking for back issues?
Browse the Archive >

Next Article
Jan-Feb 2022
CONTENTS
Page 2
PAGE VIEW